German cannabis medicine manufacturer lands $17M+ in funding
The German-based cannabis medicine producer Avextra has reeled in some new funds while also looking to expand its reach within Europe.
Avextra announced Wednesday that it secured a total of €17 million ($17.9 million) in a capital raise. The company said in a release that the cash will be going toward several avenues of its business, which include expanding the sales of its current products in new markets in Europe and boosting the development of new cannabis-based medicines and products. Avextra also plans to expand its research and development work and grow its presence in Portugal, where the company has a cultivation facility.